Zentalis Pharmaceuticals, Inc.

Q1 2025 13F Holders

Symbol
ZNTL
CUSIP
98943L107
Type
Equity
Class
COM
Num filings
137
Total reported value, excl. options
$93.0 M
Manager Report Date Value ($000) Shares Option Type